• Vaxxa’s third-quarter 2026 loss after financial items tripled year-on-year to SEK 1.5 million.
• Net sales fell 34% to SEK 13.9 million, reflecting the mix of objects sold during the quarter.
• Gross margin increased to 10.4% from 8.9% a year earlier.
• January-September net sales rose 19% to SEK 61.8 million, while gross profit climbed 58% to SEK 6.3 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxxa AB published the original content used to generate this news brief via Cision (Ref. ID: 202610200230BITN____UKPR__SV_20261019-BIT-6386-0) on October 20, 2026, and is solely responsible for the information contained therein.